// App-Quantinova.ai

: Deucravacitinib Exposure-Response Analyses in Patients With Moderate to Severe Psoriasis

Researchers

Presenter

  • Jun Shen

Principal Investigators

  • Mark Lovern

  • Matt Maloney

  • Amit Roy

  • Elizabeth Colston

  • Anjaneya Chimalakonda

Medical Centers

  • Bristol-Myers Sqiubb, Princeton, NJ

  • Certara, Princeton, NJ

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A